Motivation to quit smoking among HIV-positive smokers in Vietnam

BMC Public Health

Damon J Vidrine⁶  Carl A Latkin⁴  Huong Thu Thi Phan¹  Jennifer I Vidrine²  Michael D Swartz⁵  Christine M Markham⁵  Lu Y Hwang⁵  Bach Xuan Tran⁴  Nhung Thi Phuong Nguyen³ 

[1] Authority of HIV/AIDS Control, Ministry of Health, Hanoi, Vietnam;Department of Health Disparities Research, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;Department of Pharmacoeconomics & Pharmacoepidemiology, Hanoi University of Pharmacy, 13-15 Le Thanh Tong St, Hanoi, Vietnam;Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA;The University of Texas Health Science Center at Houston, Houston 77030, TX, USA;Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Unit 1330, Houston 77030, TX, USA

关键词: Vietnam;    HIV;    Cessation;    Quit;    Smoking;    Cigarette;   

Others  :  1164180
DOI  :  10.1186/s12889-015-1672-y

 received in 2014-12-27, accepted in 2015-03-23,  发布年份 2015

【 摘 要 】

Background

Smoking cessation is emerging as an important component in current HIV care to reduce smoking-related adverse health outcomes. This study aimed to examine motivation to quit and its associated factors in a sample of 409 HIV-positive smokers in Vietnam.

Methods

A cross-sectional survey was conducted from January to September 2013 in Hanoi (the capital) and Nam Dinh (a rural city). Motivation to quit was measured by a 4-point single item, and was dichotomized as having any motivation versus no motivation. Smoking history, nicotine dependence (Fagerstrom Test of Nicotine Dependence), and other covariates were self-reported by participants. Multivariate logistic regression was performed to identify correlates of motivation to quit.

Results

The sample was mostly male (97%). Mean age was 36 years (SD = 5.8). Approximately 37% and 69% of the sample were hazardous drinkers and ever drug users, respectively. The mean duration of HIV infection and ART treatment were 6 years (SD = 3.6) and 5 years (SD = 2.2), respectively. Overall, 59% of the sample was motivated to quit. Factors significantly associated with motivation to quit were income, pain, currently taking Methadone, and the interaction between binge drinking and lifetime drug use. Individuals with the highest income level (OR = 2.2, 95% CI = 1.3-3.6), moderate income level (OR = 1.8, 95% CI = 1.1-3.1), and currently feeling pain (OR = 1.6, 95% CI = 1.0-2.5) were more likely to be motivated to quit. Conversely, taking Methadone was associated with a lower likelihood of motivation to quit (OR = 0.4, 95% CI = 0.2-0.9). Also, those who reported binge drinking only (OR = 0.5, 95% CI = 0.3-0.9), lifetime drug use only (OR = 0.3, 95% CI = 0.1, 0.7), or both substance uses (OR = 0.4, 95% CI = 0.2, 0.8) were less motivated to quit smoking.

Conclusion

Smoking cessation treatment should be integrated into HIV care in Vietnam, and should be tailored to meet specific needs for individuals with different attitudes on smoking, low income, and polysubstance use.

【 授权许可】

   
2015 Nguyen et al.; licensee BioMed Central.

【 参考文献 】

• [1]Shirley DK, Kaner RJ, Glesby MJ: Effects of smoking on non-AIDS-related morbidity in HIV-infected patients. Clin Infect Dis 2013, 57(2):275-82.
• [2]Lifson AR, Lando HA: Smoking and HIV: prevalence, health risks, and cessation strategies. Curr HIV/AIDS Rep 2012, 9(3):223-30.
• [3]Lifson AR, Neuhaus J, Arribas JR, van den Berg-Wolf, Labriola AM, Read TR. Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial. Am J Public Health. 2010;100(10):1896–903.
• [4]Vidrine DJ, Arduino RC, Gritz ER: The effects of smoking abstinence on symptom burden and quality of life among persons living with HIV/AIDS. AIDS Patient Care STDS 2007, 21(9):659-66.
• [5]Petoumenos K, Worm S, Reiss P, de Wit S, d’Arminio Monforte A, Sabin C, et al.: Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*). HIV Med 2011, 12(7):412-21.
• [6]Niaura R, Chander G, Hutton H, Stanton C: Interventions to address chronic disease and HIV: strategies to promote smoking cessation among HIV-infected individuals. Curr HIV/AIDS Rep 2012, 9(4):375-84.
• [7]Mamary EM, Bahrs D, Martinez S: Cigarette smoking and the desire to quit among individuals living with HIV. AIDS Patient Care STDS 2002, 16(1):39-42.
• [8]Gritz ER, Vidrine DJ, Lazev AB, Amick BC 3rd, Arduino RC: Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res 2004, 6(1):71-7.
• [9]Humfleet GL, Delucchi K, Kelley K, Hall SM, Dilley J, Harrison G: Characteristics of HIV-positive cigarette smokers: a sample of smokers facing multiple challenges. AIDS Educ Prev 2009, 21(3 Suppl):54-64.
• [10]Tesoriero JM, Gieryic SM, Carrascal A, Lavigne HE: Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation. AIDS Behav 2010, 14(4):824-35.
• [11]Fuster M, Estrada V, Fernandez-Pinilla MC, Fuentes-Ferrer ME, Tellez MJ, Vergas J, et al.: Smoking cessation in HIV patients: rate of success and associated factors. HIV Med 2009, 10(10):614-9.
• [12]Shirley DK, Kesari RK, Glesby MJ: Factors associated with smoking in HIV-infected patients and potential barriers to cessation. AIDS Patient Care STDS 2013, 27(11):604-12.
• [13]Ajzen I, Fishbein M, Attitudes U, Behavior PS: Englewood Cliffs. Prentice-Hall, NJ; 1980.
• [14]Prochaska OJ, Redding AC, Evers KE: The Transtheoretical Model and Stages of Change, in Health Behavior and Health Education: Theory, Research, and Practice. Edited by Glanz Rimer BK, Viswanath K. Jossey-Bass, San Francisco, CA; 2008:97-117.
• [15]Biener L, Abrams DB: The Contemplation Ladder: validation of a measure of readiness to consider smoking cessation. Health Psychol 1991, 10(5):360-5.
• [16]Furber AS, Maheswaran R, Newell JN, Carroll C: Is smoking tobacco an independent risk factor for HIV infection and progression to AIDS? A systemic review. Sex Transm Infect 2007, 83(1):41-6.
• [17]GATS: Global Adult Tobacco Survey (GATS) Viet Nam 2010. Ministry of Health of Vietnam, General Statistics Office, Hanoi, Vietnam; 2010.
• [18]Norman RE, Vos T, Barendregt JJ, Linh BN, Huong NT, Higashi H, et al.: Mortality attributable to smoking in Vietnamese men in 2008. Prev Med 2013, 57(3):232-7.
• [19]Ross H, Trung DV, Phu VX: The costs of smoking in Vietnam: the case of inpatient care. Tob Control 2007, 16(6):405-9.
• [20]VAAC: Report on the Current Situation of HIV infection in 2013. Ministry of Health of Vietnam, Hanoi, Vietnam; 2014.
• [21]UNAIDS, HIV in Asia and the Pacific: UNAIDS report 2013. 2013. http://www.aidsdatahub.org/sites/default/files/publication/UNAIDS-2013-Asia-Pacific-report.pdf
• [22]Nguyen NP, Tran BX, Hwang LY, Markham CM, Swartz MD, Phan HT, et al.: Prevalence of cigarette smoking and associated factors in a large sample of HIV-positive patients receiving antiretroviral therapy in Vietnam. PLoS One 2015, 10(2):e0118185.
• [23]National Committee for AIDS, Drug and Prostitution Prevention and Control, Viet Nam AIDS Response progress report 2012. 2012. http://www.unaids.org/sites/default/files/en/dataanalysis/knowyourresponse/countryprogressreports/2012countries/ce_VN_Narrative_Report.pdf
• [24]Tran BX, Nguyen N, Ohinmaa A, Duong AT, Nguyen LT, Van Hoang M, et al.: Prevalence and correlates of alcohol use disorders during antiretroviral treatment in injection-driven HIV epidemics in Vietnam. Drug Alcohol Depend 2013, 127(1–3):39-44.
• [25]Vidrine DJ, Fletcher FE, Danysh HE, Marani S, Vidrine JI, Cantor SB, et al.: A randomized controlled trial to assess the efficacy of an interactive mobile messaging intervention for underserved smokers: Project ACTION. BMC Public Health 2012, 12:696. BioMed Central Full Text
• [26]Vidrine DJ, Marks RM, Arduino RC, Gritz ER: Efficacy of cell phone-delivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes. Nicotine Tob Res 2012, 14(1):106-10.
• [27]Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO: The fagerstrom test for nicotine dependence: a revision of the fagerstrom tolerance questionnaire. Br J Addict 1991, 86(9):1119-27.
• [28]Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA: The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory care quality improvement project (ACQUIP). alcohol Use disorders identification test. Arch Intern Med 1998, 158(16):1789-95.
• [29]Tran BX, Nguyen LT, Do CD, Nguyen QL, Maher RM: Associations between alcohol use disorders and adherence to antiretroviral treatment and quality of life amongst people living with HIV/AIDS. BMC Public Health 2014, 14(1):27. BioMed Central Full Text
• [30]EQOL Group, EQ-5D-5L User Guide: Basic information on how to use the EQ-5D-5L instrument. 2013. http://www.euroqol.org/fileadmin/user_upload/Documenten/PDF/Folders_Flyers/UserGuide_EQ-5D-5L_v2.0_October_2013.pdf
• [31]Tran BX, Ohinmaa A, Nguyen LT: Quality of life profile and psychometric properties of the EQ-5D-5 L in HIV/AIDS patients. Health Qual Life Outcomes 2012, 10:132. BioMed Central Full Text
• [32]Hosmer DW, Lemeshow S: Applied Logistic Regression. 2 nd edition. Wiley, NewYork; 2000.
• [33]Duval X, Baron G, Garelik D, Villes V, Dupré T, Leport C, et al.: Living with HIV, antiretroviral treatment experience and tobacco smoking: results from a multisite cross-sectional study. Antivir Ther 2008, 13(3):389-97.
• [34]Amiya RM, Poudel KC, Poudel-Tandukar K, Kobayashi J, Pandey BD, Jimba M: Physicians are a key to encouraging cessation of smoking among people living with HIV/AIDS: a cross-sectional study in the Kathmandu Valley. Nepal BMC Public Health 2011, 11:677. BioMed Central Full Text
• [35]Vidrine DJ, Fletcher FE, Buchberg MK, Li Y, Arduino RC, Gritz ER: The influence of HIV disease events/stages on smoking attitudes and behaviors: project STATE (Study of Tobacco Attitudes and Teachable Events). BMC Public Health 2014, 14:149. BioMed Central Full Text
• [36]Burkhalter JE, Springer CM, Chhabra R, Ostroff JS, Rapkin BD: Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res 2005, 7(4):511-22.
• [37]Berg CJ, Nehl EJ, Wang X, Ding Y, He N, Johnson BA, et al.: Healthcare provider intervention on smoking and quit attempts among HIV-positive versus HIV-negative MSM smokers in Chengdu. China AIDS Care 2014, 26(9):1201-7.
• [38]Lloyd-Richardson EE, Stanton CA, Papandonatos GD, Shadel WG, Stein M, Tashima K, et al.: Motivation and patch treatment for HIV+ smokers: a randomized controlled trial. Addiction 2009, 104(11):1891-900.
• [39]Schafer J, Young J, Bernasconi E, Ledergerber B, Nicca D, Calmy A, et al.: Predicting smoking cessation and its relapse in HIV-infected patients: the Swiss HIV Cohort Study. HIV Med 2015, 16(1):3-14.
• [40]Fiore MC, Jaén CR, Baker TB: Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline, Rockville, MD; 2008.
• [41]Hessol NA, Weber KM, D’Souza G, Burton D, Young M, Milam J, et al.: Smoking cessation and recidivism in the Women's Interagency Human Immunodeficiency Virus Study. Am J Prev Med 2014, 47(1):53-69.
• [42]Nahvi S, Cooperman NA: Review: the need for smoking cessation among HIV-positive smokers. AIDS Educ Prev 2009, 21(3 Suppl):14-27.
• [43]World Bank. 2013. http://data.worldbank.org/country/vietnam - cp_surv.
• [44]Reynolds NR: Cigarette smoking and HIV: more evidence for action. AIDS Educ Prev 2009, 21(3 Suppl):106-21.
• [45]Williams JM, Ziedonis D: Addressing tobacco among individuals with a mental illness or an addiction. Addict Behav 2004, 29(6):1067-83.
• [46]McCool RM, Paschall Richter K: Why do so many drug users smoke? J Subst Abuse Treat 2003, 25(1):43-9.
• [47]Marshall MM, Kirk GD, Caporaso NE, McComark MC, Merlo CA, Hague JC, et al.: Tobacco use and nicotine dependence among HIV-infected and uninfected injection drug users. Addict Behav 2011, 36(1–2):61-7.
• [48]Prochaska JJ: Failure to treat tobacco use in mental health and addiction treatment settings: a form of harm reduction? Drug Alcohol Depend 2010, 110(3):177-82.
• [49]Prochaska JJ, Delucchi K, Hall SM: A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. J Consult Clin Psychol 2004, 72(6):1144-56.
• [50]Winhusen TM, Brigham GS, Kropp F, Lindblad R, Gardin JG 2nd, Penn P, et al.: A randomized trial of concurrent smoking-cessation and substance use disorder treatment in stimulant-dependent smokers. J Clin Psychiatry 2014, 75(4):336-43.
• [51]Higashi H, Barendregt JJ: Cost-effectiveness of tobacco control policies in Vietnam: the case of personal smoking cessation support. Addiction 2012, 107(3):658-70.